Ultomiris Drug Market: Growth, Trends, and Global Forecast

adicionou um novo artigo Networking

2026-03-25 11:39:48 -

Market Overview The global Ultomiris drug market is experiencing strong growth, driven by increasing adoption of advanced biologic therapies for rare diseases. The market is projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, registering a CAGR of 14.4%. Ultomiris (ravulizumab), developed by Alexion Pharmaceuticals, is a long-acting C5...

0 Comentários 0 Compartilhamentos 4 Visualizações